Mednow Inc Stock Current Ratio

MDNWF Stock  USD 0.02  0.00  0.00%   
Mednow Inc fundamentals help investors to digest information that contributes to Mednow's financial success or failures. It also enables traders to predict the movement of Mednow Pink Sheet. The fundamental analysis module provides a way to measure Mednow's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Mednow pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Mednow Inc Company Current Ratio Analysis

Mednow's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

Current Ratio

 = 

Current Asset

Current Liabilities

More About Current Ratio | All Equity Analysis

Current Mednow Current Ratio

    
  1.83 X  
Most of Mednow's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mednow Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Competition

In accordance with the recently published financial statements, Mednow Inc has a Current Ratio of 1.83 times. This is 37.11% lower than that of the Healthcare sector and significantly higher than that of the Health Information Services industry. The current ratio for all United States stocks is 15.28% higher than that of the company.

Mednow Current Ratio Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mednow's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Mednow could also be used in its relative valuation, which is a method of valuing Mednow by comparing valuation metrics of similar companies.
Mednow is currently under evaluation in current ratio category among its peers.

Mednow Fundamentals

About Mednow Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Mednow Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mednow using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mednow Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Mednow Pink Sheet

Mednow financial ratios help investors to determine whether Mednow Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mednow with respect to the benefits of owning Mednow security.